Sialidosis Type II in Siblings with a Novel NEU1 Variant: Clinical and Molecular Genetic Analysis
- 13 October 2026
- journal article
- research article
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 525
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Sialidosis type II: Expansion of phenotypic spectrum and identification of a common mutation in seven patientsMolecular Genetics and Metabolism Reports, 2020
- Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Heterodimerization of the Sialidase NEU1 with the Chaperone Protective Protein/Cathepsin A Prevents Its Premature OligomerizationJournal of Biological Chemistry, 2009
- Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: what does success mean?Nephrology Dialysis Transplantation, 2005
- Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expressionHuman Mutation, 2003
- Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymesJournal of Human Genetics, 2002
- Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosisHuman Molecular Genetics, 2000
- Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.Genes & Development, 1996
- Acid α‐neuraminidase deficiency: a nephropathic phenotype?Clinical Genetics, 1988